Probabilities are estimated for the occurrence and observation of transits of 849 red dwarfs brighter than visual magnitude 12.0 by their close extrasolar giant (70,000 km radii) planets. The special cases of Gliese 876 and the red dwarfeclipsing binaries CM Draconis and YY Geminorum are also dis...
Tisagenlecleucel was the first CAR-T therapy and the first gene therapy to receive US Food and Drug Administration approval in 2017, with an initial indication for pediatric and young adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia, followed by approval in May 2018...